Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses (2017)
- Authors:
- USP affiliated authors: AGUIAR, PATRICIA MELO - FCF ; STORPIRTIS, SILVIA - FCF
- Unidade: FCF
- DOI: 10.1016/j.critrevonc.2017.03.014
- Subjects: MIELOMA MÚLTIPLO; ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Critical Reviews in Oncology Hematology
- ISSN: 1040-8428
- Volume/Número/Paginação/Ano: v. 113, p. 195-212, 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
AGUIAR, Patrícia Melo et al. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, v. 113, p. 195-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2017.03.014. Acesso em: 02 abr. 2026. -
APA
Aguiar, P. M., Lima, T. de M., Colleoni, G. W. B., & Storpirtis, S. (2017). Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, 113, 195-212. doi:10.1016/j.critrevonc.2017.03.014 -
NLM
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014 -
Vancouver
Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014 - Analysis of priorities in pharmaceutical assistance of the state of São Paulo
- Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients"
- Development and validation of key performance indicators for medication management services provided for outpatients
- Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study
- Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis
- Development and validation of key performance indicators for medication management services provided for outpatients
- Perception of the patients with prostate cancer about the process of communication with the pharmacist at USP university pharmacy
- The effects of pharmacist interventions on adult outpatients with cancer: a systematic review
- Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews
- Diagnóstico situacional da atuação dos Centros de Informação sobre Medicamentos no Brasil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
